Provided by Tiger Fintech (Singapore) Pte. Ltd.

I-MAB

2.50
+0.17007.30%
Post-market: 2.520.0200+0.80%19:55 EDT
Volume:368.92K
Turnover:914.46K
Market Cap:204.15M
PE:-22.45
High:2.55
Open:2.35
Low:2.33
Close:2.33
Loading ...

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

THOMSON REUTERS
·
04 Apr

Press Release: I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
04 Apr

I-Mab expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
31 Mar

I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
26 Mar

I-Mab Gets Nasdaq Noncompliance Notice on Bid Price Requirement

MT Newswires Live
·
22 Mar

BRIEF-I-Mab gets Nasdaq notice regarding minimum bid price requirement

Reuters
·
22 Mar

I-Mab Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

THOMSON REUTERS
·
22 Mar

I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

GlobeNewswire
·
22 Mar

I-Mab expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
21 Mar

I-Mab expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
11 Mar

I-Mab announces accelerated givastomig Phase 1b study progress

TIPRANKS
·
07 Mar

BRIEF-I-Mab Announces Accelerated Givastomig Phase 1B Study Progress

Reuters
·
07 Mar

I-Mab: Phase 1B Dose Escalation Data Expected to Be Presented in 2H 2025

THOMSON REUTERS
·
07 Mar

I-Mab: Topline Results From 40-Patient Dose Expansion Study Expected in 1H 2026

THOMSON REUTERS
·
07 Mar

I-Mab Announces Accelerated Givastomig Phase 1B Study Progress

THOMSON REUTERS
·
07 Mar

I-Mab Announces Accelerated Givastomig Phase 1b Study Progress

GlobeNewswire
·
07 Mar

I-Mab initiated with a Buy at Brookline

TIPRANKS
·
28 Feb

I-Mab to Participate in Leerink Partners Global Healthcare Conference

GlobeNewswire
·
18 Feb

I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
04 Feb

U.S. RESEARCH ROUNDUP-Antero Resources, IGM Biosciences, Lennar

Reuters
·
10 Jan